Drug Pipeline

GT801 Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07614191
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment…
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-29 NCT07614191 A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… Early Phase 1 Recruiting
Active Studies by Phase
Early Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Early Phase 1
NCT07205315 A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients… B-cell Acute Lymphoblastic Leukemia (B-ALL) Recruiting
NCT07333118 A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… Moderate to Severe Refractory Autoimmune Disease Recruiting
NCT07614191 A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment… Moderate to Severe Refractory Autoimmune Diseases Recruiting
Sponsors Running GT801 Injection Trials
Disease Areas
Get alerts when GT801 Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free